Abstract
Progressive hydrocephalus in the preterm infant requires judicious management. Fortunately, in some infants, short-term treatment may obviate the need for shunting procedures. This case illustrates the successful control of progressive hydrocephalus in a preterm infant managed by acetazolamide, a carbonic anhydrase inhibitor. The drug was discontinued transiently early in the course of treatment. This patient's clinical course, change in head circumference, and cerebral utrasound provide evidence of the benefit of this drug regimen in treating hydrocephalus.
This is a preview of subscription content, access via your institution.
References
Donat JF (1980) Acetazolamide induced improvement in hydrocephalus. Arch Neurol 37:376
Huttenlocher PR (1965) Treatment of hydrocephalus with acetazolamide. J Pediatr 66:1023–1030
Mealy J Jr, Barker DJ (1968) Failure of oral acetazolamide to avert hydrocephalus in infants with myelomeningocele. J Pediatr 72:257–259
Palma PA, Morriss FH, Miner ME, Denson SF, Adcock EW (1979) Prospective survey of intraventricular hemorrhage in infants less than 1800 grams. Clin Res 27:815A
Rubin RC, Henderson ES, Ommaya A, Walker MD, Rall DP (1966) The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg 25:430–436
Schain RJ (1969) Carbonic anhydrase inhibitors in chronic infantile hydrocephalus. Am J Dis Child 117:621–626
Volpe JJ (1979) Intracranial hemorrhage in the newborn: current understanding and dilemmas. Neurology 29:632–636
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Miner, M.E. Acetazolamide treatment of progressive hydrocephalus secondary to intraventricular hemorrhage in a preterm infant. Child's Nerv Syst 2, 105–106 (1986). https://doi.org/10.1007/BF00286232
Issue Date:
DOI: https://doi.org/10.1007/BF00286232